TERESA MCILVOY: Open Payments
NPI 1235580754 · DANVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,835 in 106 payments from 18 companies in 2025. Trend: 2023 $1,629 · 2024 $1,597 · 2025 $1,835
Food & beverage: $1,835
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 16 | $236 |
| ABBVIE INC. | 14 | $210 |
| E.R. Squibb & Sons, L.L.C. | 9 | $190 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $180 |
| Otsuka America Pharmaceutical, Inc. | 8 | $156 |
| Alkermes, Inc. | 6 | $118 |
| Axsome Therapeutics, Inc. | 4 | $102 |
| Janssen Pharmaceuticals, Inc | 3 | $94 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $88 |
| Biogen, Inc. | 5 | $85 |
Products named: FANAPT, VRAYLAR, COBENFY, CAPLYTA, REXULTI, Auvelity, INVEGA SUSTENNA, LYBALVI.
Industry payments across KY — which companies pay providers there.
